- Quest Diagnostics (DGX, Financial) maintains a steady dividend, bolstering return potential.
- Analysts project an average upside of 7.03% for DGX stock.
- GuruFocus indicates a potential downside in valuation estimates.
Quest Diagnostics (DGX) has announced it will maintain its quarterly dividend at $0.80 per share, offering investors a yield of 1.86%. This dividend will be payable on July 21, following the record date of July 7. In addition to this steady dividend, Quest Diagnostics is committed to achieving its 2025 revenue target of $10.7 billion to $10.85 billion. This goal is supported by strategic partnerships and advancements in diagnostics technology.
Wall Street Analysts Forecast
Analysts have presented one-year price targets for Quest Diagnostics Inc (DGX, Financial), with an average target price of $184.61. The highest estimate is $200.00, while the lowest is $158.69. This average target suggests a potential upside of 7.03% from the current price of $172.48. For more comprehensive estimate data, please visit the Quest Diagnostics Inc (DGX) Forecast page.
The consensus recommendation from 20 brokerage firms rates Quest Diagnostics Inc's (DGX, Financial) performance as "Outperform," reflected in an average brokerage recommendation of 2.2. This rating is based on a scale where 1 signifies Strong Buy and 5 indicates Sell.
According to GuruFocus estimates, the estimated GF Value for Quest Diagnostics Inc (DGX, Financial) in one year is $163.36. This suggests a potential downside of 5.29% from the current price of $172.48. The GF Value is a measure of the fair value at which the stock should ideally trade, calculated based on historical trading multiples, past business growth, and future business performance estimates. For more detailed data, visit the Quest Diagnostics Inc (DGX) Summary page.
